| 000 | 01423 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512232813.0 | ||
| 264 | 0 | _c19810827 | |
| 008 | 198108s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19810715)48:2<419::aid-cncr2820480234>3.0.co;2-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRibas-Mundo, M | |
| 245 | 0 | 0 |
_aEvaluation of a protective environment in the management of granulocytopenic patients: a comparative study. _h[electronic resource] |
| 260 |
_bCancer _cJul 1981 |
||
| 300 |
_a419-24 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAgranulocytosis _xmicrobiology |
| 650 | 0 | 4 | _aAir Microbiology |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfection Control |
| 650 | 0 | 4 |
_aLeukemia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Isolation |
| 700 | 1 | _aGranena, A | |
| 700 | 1 | _aRozman, C | |
| 773 | 0 |
_tCancer _gvol. 48 _gno. 2 _gp. 419-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19810715)48:2<419::aid-cncr2820480234>3.0.co;2-5 _zAvailable from publisher's website |
| 999 |
_c6786485 _d6786485 |
||